Published: 2021-08-27

Visibility of gastric cancer awareness programs

Namrata Hange, Manoj Reddy Somagutta, Sai Harsha Bobba, Narayana Reddy Bathula, Erkan Batti, Obumneme Jude Iloeje, Klodin Ghazarian, Gouthami Sajjanagandla, Ulhas Vasave, Bernard Emuze


Gastric cancer is one of the most common and deadliest cancers known globally. Due to historically low survival rates and available few treatment modalities, especially in developing nations with high burden incidence of gastric cancers, reducing incidence seems to be the key to reducing mortality. This article has emphasized the planning and visibility of the gastric cancer awareness program. The gastric cancer awareness programs shall help people approach health care facilities if reported to be symptomatic and help to reduce the mortality burden through early detection and access to treatment. Stomach cancer awareness programs involve sensitization of the population regarding symptom recognition, screening, identification of vulnerable people, and preventive measures focused on disease control. Recognition of people at risk, symptom screening protocol along with prevention, and management of gastric cancer is meant to achieve this Gastric cancer control strategy. Gastric cancer awareness campaign, along with identification of risk factors, shall include prevention, early detection, and potential gastric cancer treatments through appropriate programs and activities. Targeting high-risk populations including males, aged more than 40 years, smokers, obese, alcoholic, red-meat eaters, population with low socioeconomic status, and people with a positive family history of gastric cancer along for health education shall be directed towards the annual gastric cancer screening programme either free or subsidized rate. Holistic gastric cancer awareness programs encompass the integrated lifestyle modification approach-addressing a healthy balanced diet; de-addiction for smoking and alcohol and stress-free life. Specific local, country-specific strategies tailored to each country's risk factor profile shall be considered while planning a gastric cancer awareness program.


Stomach cancer, Awareness, Programs, Treatment, Gastric cancer

Full Text:



Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.

World Cancer Research Fund International/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer. 2016.

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M et al. Global cancer observatory: International Agency for Research on Cancer. 2020.

Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Current gastroenterology reports. 2017;19(8):1-0.

Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2016;27:v38-49.

Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12(1):135-8.

Suh YS, Lee J, Woo H, Shin D, Kong SH, Lee HJ et al. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. Cancer. 2020;126(9):1929-39.

Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet oncol. 2008;9(3):279-87.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer. J clin. 2021;71(3):209-49.

World Cancer Research Fund International/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Stomach Cancer. 2016.

Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Prevention Biomarkers. 20141;23(5):700-13.

Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38.

Howlader NN, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER cancer statistics review, 1975-2012. National Cancer Institute. 2014.

Cancer Research UK, Stomach Cancer Survival in UK compared to US Available at: Accessed on 13 June 2021.

Mukaisho K, Nakayama T, Hagiwara T, Hattori T, Sugihara H. Two distinct aetiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol. 2015;6:412.

Chon HJ, Hyung WJ, Kim C, Park S, Kim JH, Park CH et al. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis from a Single High-volume Center in Asia. Ann Surg. 2017;265(5):946-53.

Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS genetics. 2009;5(10):e1000676.

Berger H, Marques MS, Zietlow R, Meyer TF, Machado JC, Figueiredo C. Gastric cancer pathogenesis. Helicobacter. 2016;21:34-8.

Mohandas KM, Jagannath P. Epidemiology of digestive tract cancers in India. VI. Projected burden in the new millennium and the need for primary prevention. Indian J Gastroenterol. 2000;19(2):74-8.

Yufen Lín MS, Bailey Jr DE. Common and co-occurring symptoms experienced by patients with gastric cancer. In Oncology nursing forum. 2020;47(2):187-202.

Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756-80.

La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-55.

Eslick GD. Helicobacter pylori infection causes gastric cancer A? review of the epidemiological, meta-analytic, and experimental evidence. World j gastroenterol. 2006;12(19):2991.

Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100(5):1037-42.

Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein–Barr virus‐associated gastric carcinoma: A meta‐analysis. J gastroenterol hepatol. 2009;24(3):354-65.

Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World j gastroenterol. 2019;25(27):3546-62.

Moss SF, Shirin HA. Epidemiology and molecular epidemiology of gastric cancer. Gastrointestinal oncolo. 2004.

Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R et al. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):42-54.

Santibañez M, Alguacil J, de la Hera MG, Navarrete-Muñoz EM, Llorca J, Aragonés N et al. Occupational exposures and risk of stomach cancer by histological type. Occupational Environmental Med. 2012;69(4):268-75.

Krstev S, Dosemeci M, Lissowska J, Chow WH, Zatonski W, Ward MH. Occupation and risk of stomach cancer in Poland. Occupational Environmental Med. 2005;62(5):318-24.

Watabe H, Mitsushima T, Yamaji Y. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764-8.

Vaananen H, Vauhkonen M, Helske T. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum level of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol. 2003;15:885-91.

Tashiro A, Sano M, Kinameri K. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12:4874-5.

Hamashima C, Yoshimura K, Fukao A. A study protocol for expanding the screening interval of endoscopic screening for gastric cancer based on individual risks: prospective cohort study of gastric cancer screening. Ann Translational Med. 2020;8(23).

Suh YS, Lee J, Woo H, Shin D, Kong SH, Lee HJ et al. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. Cancer. 2020;126(9):1929-39.

Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: A global perspective. J gastroenterol hepatol. 2020;35(9):1495-502.

Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449-72.

Sitarz R, Skierucha M, Mielko J, Offerhaus G, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer management res. 2018;10:239-48.

Roberto S. Subtotal gastrectomy for gastric cancer. World j gastroenterol. 2014;20(38):13667-80.

Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell. 2004;5(2):121-5.

Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM et al. Gastric adenocarcinoma: a multimodal approach. Frontiers surg. 2017;3;4:42.

Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing trends in gastric Cancer surgery. Balkan med j. 2017;34(1):10.

Charalampakis N, Economopoulou P, Kotsantis I, Tolia M, Schizas D, Liakakos T et al. Medical management of gastric cancer: a 2017 update. Cancer med. 2018;7(1):123-33.

Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20(18):5191-204.

Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X. Prevention of gastric cancer: eradication of Helicobacter pylori and beyond. Int j molecular sci. 2017;18(8):1699.

Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: A global perspective. J gastroenterol hepatol. 2020;35(9):1495-502.

Du Y, Zhu H, Liu J, Li J, Chang X, Zhou L et al. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). J gastroenterol hepatol. 2020;35(4):624-9.

Power E, Wardle J. Change in public awareness of symptoms and perceived barriers to seeing a doctor following Be Clear on Cancer campaigns in England. Br J Cancer. 2015;112:S22-6.

Schliemann D, Su TT, Paramasivam D, Treanor C, Dahlui M, Loh SY et al. Effectiveness of mass and small media campaigns to improve cancer awareness and screening rates in Asia: a systematic review. J global oncol. 2019;5:1-20.